The traditionally risk-averse clinical trial industry has started to explore more advanced technologies in order to evolve how trials are run - exploring topics like real-world data capture, decentralized trial execution, faster patient enrollment, and better trial data analytics. In this session, learn how these new technologies are enabling smarter trial design, intended to generate better insights and accelerate time to patient.

As complexity increases, trial managers are looking to technology to help reduce the administrative burden. Join Marion Mays as she looks at the past, present and future of eTMF development.

Phillip Doyle from Doyle GxP discusses GxP principles for small biotechs. Covering areas such as when in the drug development journey quality and compliance principles should apply, how to apply them, and why GxP guidelines are important for creating an early culture of quality, you won't want to miss this session.